In 2019, Huang et al. obtained similar results in their meta-analysis of 29 studies involving 3543 cases of 13 different cancers, confirming the association between Gal-1 and decreased survival (HR: 2.12; 95% CI: 1.71–2.64; p < 0.001) [69]. This evidence concerns the gene LGALS1 and cancer.